vs
BGSF, INC.（BGSF）与CUMBERLAND PHARMACEUTICALS INC（CPIX）财务数据对比。点击上方公司名可切换其他公司
BGSF, INC.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.6倍（$22.0M vs $13.7M），BGSF, INC.净利率更高（-5.3% vs -10.3%，领先5.1%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -9.4%），BGSF, INC.自由现金流更多（$1.7M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs -5.3%）
BGSF Inc.是一家总部位于美国的领先人力资源解决方案提供商，提供定制化人员派遣、人才招聘和全流程劳动力管理服务，覆盖信息技术、医疗健康、专业行政、轻工业、创意产业等核心领域，服务北美各规模的企业客户。
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
BGSF vs CPIX — 直观对比
营收规模更大
BGSF
是对方的1.6倍
$13.7M
营收增速更快
CPIX
高出40.5%
-9.4%
净利率更高
BGSF
高出5.1%
-10.3%
自由现金流更多
BGSF
多$1.7M
$3.0K
两年增速更快
CPIX
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.0M | $13.7M |
| 净利润 | $-1.2M | $-1.4M |
| 毛利率 | 35.0% | 83.6% |
| 营业利润率 | -17.6% | -10.0% |
| 净利率 | -5.3% | -10.3% |
| 营收同比 | -9.4% | 31.1% |
| 净利润同比 | -18.2% | 25.8% |
| 每股收益（稀释后） | $-0.12 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGSFCPIX
| Q4 25 | $22.0M | $13.7M | ||
| Q3 25 | $26.9M | $8.3M | ||
| Q2 25 | $23.5M | $10.8M | ||
| Q1 25 | $20.9M | $11.7M | ||
| Q4 24 | $24.3M | $10.4M | ||
| Q3 24 | $29.8M | $9.1M | ||
| Q2 24 | $25.7M | $9.8M | ||
| Q1 24 | $24.5M | $8.5M |
净利润BGSFCPIX
| Q4 25 | $-1.2M | $-1.4M | ||
| Q3 25 | $-5.8M | $-1.9M | ||
| Q2 25 | $-3.7M | $-740.7K | ||
| Q1 25 | $-722.0K | $1.3M | ||
| Q4 24 | $-981.0K | $-1.9M | ||
| Q3 24 | $-804.0K | $-1.5M | ||
| Q2 24 | $-761.0K | $-1.1M | ||
| Q1 24 | $-792.0K | $-1.9M |
毛利率BGSFCPIX
| Q4 25 | 35.0% | 83.6% | ||
| Q3 25 | 35.9% | 88.1% | ||
| Q2 25 | 35.8% | 81.4% | ||
| Q1 25 | 36.2% | 87.8% | ||
| Q4 24 | 35.9% | 81.1% | ||
| Q3 24 | 35.9% | 85.4% | ||
| Q2 24 | 37.3% | 82.6% | ||
| Q1 24 | 38.1% | 81.5% |
营业利润率BGSFCPIX
| Q4 25 | -17.6% | -10.0% | ||
| Q3 25 | -3.5% | -23.7% | ||
| Q2 25 | -18.8% | -6.9% | ||
| Q1 25 | 1.6% | 11.0% | ||
| Q4 24 | -15.7% | -17.7% | ||
| Q3 24 | -3.4% | -18.6% | ||
| Q2 24 | -5.7% | -10.4% | ||
| Q1 24 | 1.7% | -22.0% |
净利率BGSFCPIX
| Q4 25 | -5.3% | -10.3% | ||
| Q3 25 | -21.6% | -23.4% | ||
| Q2 25 | -15.9% | -6.8% | ||
| Q1 25 | -3.5% | 10.7% | ||
| Q4 24 | -4.0% | -18.2% | ||
| Q3 24 | -2.7% | -17.0% | ||
| Q2 24 | -3.0% | -11.0% | ||
| Q1 24 | -3.2% | -22.9% |
每股收益（稀释后）BGSFCPIX
| Q4 25 | $-0.12 | $-0.09 | ||
| Q3 25 | $-0.52 | $-0.13 | ||
| Q2 25 | $-0.34 | $-0.05 | ||
| Q1 25 | $-0.06 | $0.08 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.07 | $-0.11 | ||
| Q2 24 | $-0.07 | $-0.08 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $11.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.1M | $24.9M |
| 总资产 | $57.8M | $76.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BGSFCPIX
| Q4 25 | — | $11.4M | ||
| Q3 25 | $41.2M | $15.2M | ||
| Q2 25 | $2.8M | $16.1M | ||
| Q1 25 | $2.0M | $15.1M | ||
| Q4 24 | $32.0K | $18.0M | ||
| Q3 24 | $262 | $17.5M | ||
| Q2 24 | $226 | $17.3M | ||
| Q1 24 | $50 | $18.5M |
股东权益BGSFCPIX
| Q4 25 | $48.1M | $24.9M | ||
| Q3 25 | $50.7M | $26.1M | ||
| Q2 25 | $78.3M | $28.0M | ||
| Q1 25 | $81.8M | $28.7M | ||
| Q4 24 | $82.3M | $22.9M | ||
| Q3 24 | $82.9M | $24.8M | ||
| Q2 24 | $83.2M | $26.3M | ||
| Q1 24 | $83.6M | $27.5M |
总资产BGSFCPIX
| Q4 25 | $57.8M | $76.8M | ||
| Q3 25 | $83.6M | $65.9M | ||
| Q2 25 | $149.7M | $67.9M | ||
| Q1 25 | $152.3M | $69.9M | ||
| Q4 24 | $150.1M | $75.6M | ||
| Q3 24 | $157.3K | $76.7M | ||
| Q2 24 | $159.8K | $78.5M | ||
| Q1 24 | $170.6K | $81.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | $3.0K |
| 自由现金流经营现金流 - 资本支出 | $1.7M | $3.0K |
| 自由现金流率自由现金流/营收 | 7.6% | 0.0% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-16.0K | $4.8M |
8季度趋势，按日历期对齐
经营现金流BGSFCPIX
| Q4 25 | $1.7M | $3.0K | ||
| Q3 25 | $-4.8M | $187.2K | ||
| Q2 25 | $2.2M | $843.8K | ||
| Q1 25 | $1.1M | $3.9M | ||
| Q4 24 | $3.2M | $1.9M | ||
| Q3 24 | $6.5M | $475.5K | ||
| Q2 24 | $7.3M | $-855.7K | ||
| Q1 24 | $7.4M | $-2.1M |
自由现金流BGSFCPIX
| Q4 25 | $1.7M | $3.0K | ||
| Q3 25 | $-4.9M | $163.4K | ||
| Q2 25 | $2.1M | $817.3K | ||
| Q1 25 | $1.0M | $3.9M | ||
| Q4 24 | $2.5M | $1.9M | ||
| Q3 24 | $6.5M | $460.1K | ||
| Q2 24 | $7.3M | $-862.8K | ||
| Q1 24 | $6.9M | $-2.2M |
自由现金流率BGSFCPIX
| Q4 25 | 7.6% | 0.0% | ||
| Q3 25 | -18.1% | 2.0% | ||
| Q2 25 | 9.1% | 7.5% | ||
| Q1 25 | 5.0% | 32.9% | ||
| Q4 24 | 10.2% | 18.2% | ||
| Q3 24 | 21.7% | 5.1% | ||
| Q2 24 | 28.5% | -8.8% | ||
| Q1 24 | 28.1% | -25.6% |
资本支出强度BGSFCPIX
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.4% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 3.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 2.0% | 0.5% |
现金转化率BGSFCPIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.10× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
CPIX
暂无分部数据
